No abstract available
MeSH terms
-
Adult
-
Alemtuzumab / administration & dosage
-
Alemtuzumab / therapeutic use*
-
COVID-19 / complications
-
COVID-19 / immunology*
-
Humans
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / therapeutic use*
-
Lymphocyte Depletion*
-
Male
-
Multiple Sclerosis / complications
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / immunology*
-
T-Lymphocyte Subsets / drug effects*
-
Treatment Outcome
Substances
-
Immunologic Factors
-
Alemtuzumab